Foster Victor Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Foster Victor Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1M	Buy	31,606 +852	+3%	+$378K	0.79%	57
2026 Q1	$13.7M	Sell	30,754 -2,175	-7%	-$1.01M	0.78%	57
2025 Q4	$14.5M	Sell	32,929 -928	-3%	-$400K	0.85%	52
2025 Q3	$13.7M	Buy	33,857 +8,493	+33%	+$3.55M	0.85%	55
2025 Q2	$12.1M	Buy	25,364 +2,440	+11%	+$1.12M	0.82%	57
2025 Q1	$11.1M	Sell	22,924 -1,664	-7%	-$775K	0.89%	54
2024 Q4	$10.4M	Buy	24,588 +3,062	+14%	+$1.42M	0.79%	59
2024 Q3	$10.1M	Sell	21,526 -9,061	-30%	-$4.35M	0.81%	55
2024 Q2	$15M	Sell	30,587 -3,183	-9%	-$1.38M	1.25%	25
2024 Q1	$13.5M	Buy	33,770 +2,867	+9%	+$1.21M	1.23%	35
2023 Q4	$13M	Sell	30,903 -1,624	-5%	-$600K	1.33%	29
2023 Q3	$11.7M	Buy	32,527 +18,309	+129%	+$6.4M	1.37%	24
2023 Q2	$4.95M	Buy	14,218 +458	+3%	+$154K	0.55%	62
2023 Q1	$4.33M	Buy	13,760 +518	+4%	+$155K	0.52%	72
2022 Q4	$3.84M	Sell	13,242 -609	-4%	-$186K	0.49%	75
2022 Q3	$4.14M	Sell	13,851 -324	-2%	-$93.2K	0.6%	59
2022 Q2	$4.13M	Sell	14,175 -3,562	-20%	-$953K	0.61%	61
2022 Q1	$4.83M	Sell	17,737 -5,196	-23%	-$1.23M	0.66%	58
2021 Q4	$5.19M	Buy	22,933 +2,121	+10%	+$412K	0.71%	57
2021 Q3	$3.77M	Buy	20,812 +1,569	+8%	+$306K	0.6%	59
2021 Q2	$3.88M	Buy	19,243 +4,760	+33%	+$996K	0.65%	52
2021 Q1	$3.13M	Buy	+14,483	New	+$3.18M	0.58%	52

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Foster Victor Wealth Advisors's VRTX Position: Q2 2026 in Review

Foster Victor Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, buying an estimated $378K and bringing the position to 31,606 shares worth $15.1M. The position accounts for 0.79% of the portfolio, ranked #57.

Foster Victor Wealth Advisors first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Foster Victor Wealth Advisors held 31,606 shares of Vertex Pharmaceuticals worth $15.1M as of Q2 2026.
Foster Victor Wealth Advisors bought 852 Vertex Pharmaceuticals shares in Q2 2026, an estimated $378K.
Vertex Pharmaceuticals made up 0.79% of Foster Victor Wealth Advisors's portfolio in Q2 2026, its #57 holding.
Foster Victor Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Foster Victor Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.